+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Therapy, Internal Beam Radiation Therapy), by Application, by Technology, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4613457
  • Report
  • February 2020
  • Region: Global
  • 80 pages
  • Grand View Research

FEATURED COMPANIES

  • Accuray Inc.
  • C.R. Bard, Inc. (BD)
  • Curium
  • Elekta AB
  • Isoray Medical
  • Mevion Medical Systems
  • MORE
The global radiation oncology market size is expected to reach USD 11.5 billion by 2027, registering a CAGR of 7.3% over the forecast period. Increasing prevalence of cancer is one of the major factors driving the market growth.

Rising technological advancements in radiation therapy is expected to increase the adoption of radiation oncology. For instance, in April 2019, Accuray Incorporated launched Synchrony motion tracking and correction technology for Radixact system. This technology improves dose accuracy and treatment times and is relatively more effective when compared to conventional radiosurgery therapy systems. Such advancements in technology is expected to boost the market growth.

Key players in the market focus on strategic initiatives such as collaborations, new product developments, and acquisitions. For instance, in August 2019, Mevion Medical Systems and C-RAD integrated MEVION S250i Proton Therapy System and C-RAD Catalyst PT. Integration of these products supports seamless workflow throughout the treatment with patient tracking and monitoring from setup through treatment.

Rising adoption of radiotherapy by medical centers and hospitals is expected to drive the market growth. For instance, according to an article published in Seminars in Radiation Oncology in 2017, it is estimated that more than 12,000 additional treatment machines will be required by 2035 in low- and middle-income countries alone. Furthermore, by 2035, China, India, and Brazil are estimated to require over 3,800, 1,200, and 400 additional machines, respectively.

Key initiatives are being undertaken by the U.S. government to facilitate and support R&D in oncology. Cancer Moonshot, RAS Initiative, and NCI Community Oncology Research Program are some of the initiatives undertaken by the U.S. government and are expected to have a positive impact on market growth.

Further key findings from the study suggest:
  • External Beam Radiation Therapy (EBRT) dominated the radiation oncology market in 2019 owing to high availability and penetration of sophisticated diagnostic tools and increase in awareness about available treatment options
  • Brachytherapy is projected to account for the largest share through the forecast period due to extensive usage of brachytherapy for the treatment of prostate and breast cancer
  • EBRT emerged as the largest application segment as this therapy is non-invasive and is used for the treatment of prostate, breast, lung, colorectal, head, and neck cancer owing to its ability to treat cancers in inoperable patients
  • The growth of the 3-D CRT technology segment is attributed to its precise radiation treatment and ability of radiation beams to form the same shape as the tumor at the specific site of cancer
  • North America dominated the global market in 2019. Presence of major players, reimbursement policies, and developed health infrastructure are the key factors driving the regional market growth
  • Key players operating in the market include Accuray, Inc., Nordion (Canada) Inc., Varian Medical Systems, IsoRay, Inc., Ion Beam Applications SA, Elekta AB, C.R. Bard, Inc., Mallinckrodt Public Ltd., Mevion Medical Systems, and NTP Radioisotopes SOC. Ltd.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accuray Inc.
  • C.R. Bard, Inc. (BD)
  • Curium
  • Elekta AB
  • Isoray Medical
  • Mevion Medical Systems
  • MORE
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation

Chapter 4 Market Definitions

Chapter 5 Industry Outlook
5.1 Market variable Analysis
5.1.1 Rising adoption of radiotherapy
5.1.2 Technological advancements in radiotherapy
5.1.3 Rising prevalence of cancer
5.1.4 Increase in healthcare expenditure
5.2 Market Restraint Analysis
5.2.1 Lack of skilled radiotherapy professionals
5.2.2 Inadequate radiation infrastructure
5.2.3 Adverse effects of radiotherapy
5.3 Key Opportunities Prioritized

Chapter 6 Business Environment Analysis
6.1 SWOT Analysis; by factor (Political & legal, economic and technological)
6.2 Porter’s Five Forces analysis

Chapter 7 Regulatory and Political Forces
7.1 Regulatory Landscape
7.1.1 North America
7.1.2 Europe
7.1.3 Asia Pacific
7.1.4 Latin America
7.1.5 Middle East and Africa

Chapter 8 Competitive Analysis
8.1 Vendor Landscape
8.1.1 List of key distributors and channel partners
8.1.2 Key company market share analysis, 2019
8.2 Public Companies
8.2.1 Company market position analysis
8.2.2 Competitive Dashboard Analysis
8.3 Private Companies
8.3.1 List of key emerging companies /technology disruptors/innovators
8.3.2 Regional network map

Chapter 9 Type Business Analysis
9.1 Radiation oncology market: External beam radiation therapy (EBRT) type outlook and key takeaways
9.1.1 Radiation Oncology Market: External Beam Radiation Therapy (EBRT) TYPE Movement Analysis
9.1.1.1 Electron-emitting high energy linear accelerators
9.1.1.1.1 Electron-emitting high energy linear accelerators EBRT market, 2016 - 2027 (USD Million)
9.1.1.2 Compact advanced radiotherapy systems
9.1.1.2.1 Compact advanced radiotherapy systems EBRT market, 2016 - 2027 (USD Million)
9.1.1.2.2 CyberKnife
9.1.1.2.2.1 CyberKnife Compact advanced radiotherapy systems EBRT market, 2016 - 2027 (USD Million)
9.1.1.2.3 Gamma Knife
9.1.1.2.3.1 Gamma Knife Compact advanced radiotherapy systems EBRT market, 2016 - 2027 (USD Million)
9.1.1.2.4 Tomotherapy
9.1.1.2.4.1 Tomotherapy Compact advanced radiotherapy systems EBRT market, 2016 - 2027 (USD Million)
9.1.1.3 Proton therapy
9.1.1.3.1 Proton therapy EBRT market, 2016 - 2027 (USD Million)
9.1.1.3.2 Cyclotron
9.1.1.3.2.1 Cyclotron Proton therapy EBRT market, 2016 - 2027 (USD Million)
9.1.1.3.3 Synchrotron
9.1.1.3.4 Synchrotron Proton therapy EBRT market, 2016 - 2027 (USD Million)
9.2 Radiation oncology market: Internal beam radiation therapy (IBRT) type outlook and key takeaways
9.2.1 Radiation Oncology Market: Internal beam radiation therapy (IBRT) Type Movement Analysis
9.2.1.1 Brachytherapy
9.2.1.1.1 Brachytherapy IBRT market, 2016 - 2027 (USD Million)
9.2.1.1.2 Seeds
9.2.1.1.2.1 Seeds Brachytherapy IBRT market, 2016 - 2027 (USD Million)
9.2.1.1.3 Applicators and after-loaders
9.2.1.1.3.1 Applicators and after-loaders Brachytherapy IBRT market, 2016 - 2027 (USD Million)
9.2.1.1.4 Electronic brachytherapy
9.2.1.1.4.1 Electronic brachytherapy IBRT market, 2016 - 2027 (USD Million)
9.2.1.2 Systemic Beam Radiation Therapy
9.2.1.2.1 Systemic Beam Radiation Therapy IBRT market, 2016 - 2027 (USD Million)
9.2.1.3 Others
9.2.1.3.1 Others IBRT market, 2016 - 2027 (USD Million)

Chapter 10 Technology Mode Business Analysis
10.1 Radiation oncology market: External beam radiation therapy (EBRT) technology outlook and key takeaways
10.1.1 Radiation Oncology Market: External beam radiation therapy (EBRT) Technology Movement Analysis
10.1.1.1 Image-Guided Radiation Therapy (IGRT)
10.1.1.1.1 IGRT EBRT market, 2016 - 2027 (USD Million)
10.1.1.2 Intensity Modulated Radiotherapy (IMRT)
10.1.1.2.1 IMRT EBRT market, 2016 - 2027 (USD Million)
10.1.1.3 Stereotactic radiotherapy
10.1.1.4 Stereotactic radiotherapy EBRT market, 2016 - 2027 (USD Million)
10.1.2 Proton beam therapy
10.1.2.1 Proton beam therapy EBRT market, 2016 - 2027 (USD Million)
10.1.3 3D Conformal Radiotherapy (3D-CRT)
10.1.3.1 3D-CRT EBRT market, 2016 - 2027 (USD Million)
10.1.4 Volumetric Modulated Arc Therapy (VMAT)
10.1.4.1 VMAT EBRT market, 2016 - 2027 (USD Million)
10.2 Radiation oncology market: Brachytherapy technology outlook and key takeaways
10.2.1 Radiation Oncology Market: Brachytherapy Technology Movement Analysis
10.2.1.1 Low Dose Rate (LDR) brachytherapy
10.2.1.1.1 LDR brachytherapy market, 2016 - 2027 (USD Million)
10.2.1.2 High Dose Rate (HDR) brachytherapy
10.2.1.2.1 HDR brachytherapy market, 2016 - 2027 (USD Million)
10.2.1.3 Systemic Beam Radiotherapy
10.2.1.3.1 Systemic beam radiotherapy brachytherapy market, 2016 - 2027 (USD Million)
10.2.1.4 Others
10.2.1.4.1 Others Brachytherapy market, 2016 - 2027 (USD Million)

Chapter 11 Application Mode Business Analysis
11.1 Radiation oncology market: External beam radiation therapy (EBRT) application outlook and key takeaways
11.1.1 Radiation Oncology Market: External beam radiation therapy (EBRT) Application Movement Analysis
11.1.1.1 Prostate cancer
11.1.1.1.1 Prostate cancer EBRT market, 2016 - 2027 (USD Million)
11.1.1.2 Breast cancer
11.1.1.2.1 Breast cancer EBRT market, 2016 - 2027 (USD Million)
11.1.1.3 Lung cancer
11.1.1.3.1 Lung cancer EBRT market, 2016 - 2027 (USD Million)
11.1.1.4 Head and neck cancer
11.1.1.4.1 Head and neck cancer EBRT market, 2016 - 2027 (USD Million)
11.1.1.5 Colorectal cancer
11.1.1.5.1 Colorectal cancer EBRT market, 2016 - 2027 (USD Million)
11.1.1.6 Others
11.1.1.6.1 Others EBRT market, 2016 - 2027 (USD Million)
11.2 Radiation oncology market: Internal beam radiation therapy (IBRT) application outlook and key takeaways
11.2.1 Radiation Oncology Market: Internal beam radiation therapy (IBRT) Application Movement Analysis
11.2.1.1 Prostate cancer
11.2.1.1.1 Prostate cancer IBRT market, 2016 - 2027 (USD Million)
11.2.1.2 Gynecologic cancer
11.2.1.2.1 Gynecologic cancer IBRT market, 2016 - 2027 (USD Million)
11.2.1.3 Breast cancer
11.2.1.3.1 Breast cancer IBRT market, 2016 - 2027 (USD Million)
11.2.1.4 Cervical cancer
11.2.1.4.1 Cervical cancer IBRT market, 2016 - 2027 (USD Million)
11.2.1.5 Penile cancer
11.2.1.5.1 Penile cancer IBRT market, 2016 - 2027 (USD Million)
11.2.1.6 Others
11.2.1.6.1 Others IBRT market, 2016 - 2027 (USD Million)

Chapter 12 Regional Business Analysis
12.1 Radiation Oncology Market: Regional Movement Analysis
12.2 North America
12.2.1 North America Market Estimates and Forecast, 2016 - 2027
12.2.2 U.S.
12.2.2.1 U.S. Market Estimates and Forecast, 2016 - 2027
12.2.3 Canada
12.2.3.1 Canada Market Estimates and Forecast, 2016 - 2027
12.3 Europe
12.3.1 Europe Market Estimates and Forecast, 2016 - 2027
12.3.2 Germany
12.3.2.1 Germany Market Estimates and Forecast, 2016 - 2027
12.3.3 U.K.
12.3.3.1 U.K. Market Estimates and Forecast, 2016 - 2027
12.3.4 France
12.3.4.1 France Market Estimates and Forecast, 2016 - 2027
12.3.5 Italy
12.3.5.1 Italy Market Estimates and Forecast, 2016 - 2027
12.3.6 Spain
12.3.6.1 Spain Market Estimates and Forecast, 2016 - 2027
12.3.7 Russia
12.3.7.1 Russia Market Estimates and Forecast, 2016 - 2027
12.4 Asia Pacific
12.4.1 Asia Pacific Market Estimates and Forecast, 2016 - 2027
12.4.2 Japan
12.4.2.1 Japan Market Estimates and Forecast, 2016 - 2027
12.4.3 China.
12.4.3.1 China Market Estimates and Forecast, 2016 - 2027
12.4.4 India
12.4.4.1 India Market Estimates and Forecast, 2016 - 2027
12.4.5 South Korea
12.4.5.1 South Korea Market Estimates and Forecast, 2016 - 2027
12.4.6 Australia
12.4.6.1 Australia Market Estimates and Forecast, 2016 - 2027
12.4.7 Singapore
12.4.7.1 Singapore Market Estimates and Forecast, 2016 - 2027
12.5 Latin America
12.5.1 Latin America Market Estimates and Forecast, 2016 - 2027
12.5.2 Brazil
12.5.2.1 Brazil Market Estimates and Forecast, 2016 - 2027
12.5.3 Mexico
12.5.3.1 Mexico Market Estimates and Forecast, 2016 - 2027
12.5.4 Argentina
12.5.4.1 Argentina Market Estimates and Forecast, 2016 - 2027
12.6 Middle East & Africa
12.6.1 Middle East and Africa Market Estimates and Forecast, 2016 - 2027
12.6.2 South Africa
12.6.2.1 South Africa Market Estimates and Forecast, 2016 - 2027
12.6.3 Saudi Arabia
12.6.3.1 Saudi Arabia Market Estimates and Forecast, 2016 - 2027
12.6.4 UAE
12.6.4.1 UAE Market Estimates and Forecast, 2016 - 2027

Chapter 13 COMPANY PROFILES
13.1 Varian Medical Systems, Inc.
13.1.1 Company overview
13.1.2 Financial performance
13.1.3 Product benchmarking
13.1.4 Strategic initiatives
13.2 Elekta AB
13.2.1 Company overview
13.2.2 Financial performance
13.2.3 Product benchmarking
13.2.4 Strategic initiatives
13.3 Accuray Inc.
13.3.1 Company overview
13.3.2 Financial performance
13.3.3 Product benchmarking
13.3.4 Strategic initiatives
13.4 Ion Beam Applications (IBA).
13.4.1 Company overview
13.4.2 Financial performance
13.4.3 Product benchmarking
13.4.4 Strategic initiatives
13.5 C.R. Bard, Inc. (BD)
13.5.1 Company overview
13.5.2 Financial performance
13.5.3 Product benchmarking
13.5.4 Strategic initiatives
13.6 Isoray Medical
13.6.1 Company overview
13.6.2 Financial performance
13.6.3 Product benchmarking
13.6.4 Strategic initiatives
13.7 Mevion Medical Systems
13.7.1 Company overview
13.7.2 Financial performance
13.7.3 Product benchmarking
13.7.4 Strategic initiatives
13.8 Nordion Inc.
13.8.1 Company overview
13.8.2 Financial performance
13.8.3 Product benchmarking
13.8.4 STRATEGIC INITIATIVES
13.9 NTP Radioisotopes SOC Ltd.
13.9.1 Company overview
13.9.2 Financial performance
13.9.3 Product benchmarking
13.9.4 Strategic initiatives
13.10 Curium
13.10.1 Company overview
13.10.2 Product benchmarking
Note: Product cover images may vary from those shown
  • Varian Medical Systems, Inc.
  • Elekta AB
  • Accuray Inc.
  • Ion Beam Applications (IBA).
  • C.R. Bard, Inc. (BD)
  • Isoray Medical
  • Mevion Medical Systems
  • Nordion Inc.
  • NTP Radioisotopes SOC Ltd.
  • Curium
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll